Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (27,412,260)	$ (22,162,767)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,098,935	194,698
Gain on forgiveness of debt	(1,201,857)	(178,250)
Amortization of debt discount	867,572
Share-based payments	13,109,135	13,957,145
Change in operating assets and liabilities:
Inventory	(1,675,394)	(549,825)
Accounts receivable	(512,826)
Prepaid expenses and other assets	79,224	(795,365)
Deferred charges	1,200,916
Deferred revenues	(74,111)
Operating lease liabilities	(215,743)	(28,521)
Accretion operating lease liabilities	890,474
Other assets		(161,358)
Royalty obligation		(900,000)
Accounts payable and accrued expenses	2,753,572	897,256
Net cash used in operating activities	(10,092,363)	(9,726,987)
Cash flows from investing activities:
Purchase of debt securities	(136,033)	(7,441,617)
Proceeds from disposition of debt securities	7,572,136
Acquisition, net of cash acquired	(4,206,200)
Purchase of property and equipment	(119,942)	(257,907)
Payment of patent costs and other intangibles		(137,645)
Net cash provided by (used in) investing activities	3,109,961	(7,837,169)
Cash flows from financing activities:
Proceeds from issuance of common stock- offerings	8,723,461	23,100,000
Placement costs	(491,932)	(2,548,000)
Proceeds from exercise of options and warrants		390,624
Proceeds from line of credit	6,197,695
Proceeds from issuance of convertible notes	10,350,000
Dividends paid		(32,504)
Principal repayments of notes payable	(5,147,300)	(202,503)
Net cash provided by financing activities	19,631,924	20,707,617
Increase in cash, cash equivalents and restricted cash	12,649,522	3,143,461
Cash, cash equivalents, and restricted cash at beginning of period	9,461,597	10,426,249
Cash, cash equivalents and restricted cash at end of period	22,111,119	13,569,710
Supplementary disclosure of non-cash financing activities:
Preferred stock conversion to common	220,099	3,094,134
Assets acquired excluding identifiable intangible assets and goodwill and cash	7,090,094
Liabilities assumed and consideration payable	19,755,903
Identifiable intangible assets and goodwill, net of cash outlay	19,993,525
Debt discount	5,569,978
Fair value of shares issued pursuant to antidilutive provisions		4,691,022
Fair value of shares issued pursuant to acquisition	7,327,716
Fair value of shares issued pursuant to extinguishment of debt	2,040,231
Right-of-use assets and operating lease liabilities		23,621,267
Cash paid during the period for:
Interest	$ 666,539	$ 303,957